EUR · 1,295 valued
€282 million
Supplier · public contract awards
Gilead Sciences, Lda. public contracts.
Gilead Sciences, Lda. has won 1,601 public contracts between 2009 and 2026 from 72 public buyers in 2 countries. Its most frequent buyer is Centro Hospitalar e Universitário de Coimbra, E. P. E (356 awards). Besides Portugal, it has won contracts in Poland. Outside TED, published values total €282 million across 1,295 awards. 245 awards were published on TED; the median contract size is about €270,000 (150 contracts with a value).
1,601Contracts won
72Public buyers
2Countries
Jul 2026Latest award
Latest contracts won
Portugália – Gyógyszerészeti termékek – 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
28 Jul 2026Awarded
Portugália – Gyógyszerészeti termékek – 2025/1589 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
21 Jul 2026Awarded
Portugália – Gyógyszerészeti termékek – 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
14 Jul 2026Awarded
Portugália – Különböző gyógyszerek – ANTIVIRICOS - 3 MESES
Awarded by Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) · Portugal
9 Jul 2026Awarded
Portugália – Gyógyszerészeti termékek – 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
27 May 2026Awarded
Portugália – Gyógyszerészeti termékek – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
27 May 2026Awarded
Portugália – Gyógyszerészeti termékek – Aquisição do medicamento Brexucabtagene autoleucel
Awarded by Instituto Português de Oncologia do Porto Francisco Gentil, EPE · Portugal
8 Apr 2026Awarded
Portugália – Gyógyszerészeti termékek – Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV
Awarded by Instituto Português de Oncologia do Porto Francisco Gentil, EPE · Portugal
3 Apr 2026Awarded
Portugália – Különböző gyógyszerek – ANTIVÍRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA -1º SEMESTRE
Awarded by Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) · Portugal
27 Mar 2026Awarded
Portugália – Daganatellenes és immunmodulátor szerek – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO]
Awarded by Unidade Local de Saúde Santa Maria, E.P.E · Portugal
16 Dec 2025Awarded
Contracts won by year
Contracts won by year
from the published recordsPublished value, by currency (feeds other than TED)
Typical contract size on TED
EUR · median of 150 contracts
€270,000
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against Gilead Sciences, Lda.?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding See open tenders